Trials / Completed
CompletedNCT03465332
Use of Diagnostic Measures in Chronic Obstructive Pulmonary Disease (COPD) in Routine Practice and Their Impact on Treatment Decisions
Use of Diagnostic Measures (Including Blood Eosinophil Counts) and Their Impact on Lung Specialists' Treatment Decisions in Patients With COPD in Germany
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 251 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 35 Years
- Healthy volunteers
- —
Summary
This study will evaluate the diagnostic measures (including blood eosinophil counts) commonly used by lung specialist's in routine clinical care of subjects with COPD in Germany and how these diagnostic tests influence the physician's treatment decisions. The study will be conducted in three parts. In the first part, lung specialist's, who will not participate in the survey, will develop doctor's questionnaire. The second part is an interventional cross-sectional study, wherein approximately 30 lung specialists will be enrolled and data on their perspective on diagnosis and treatment of COPD subjects will be collected via the revised doctor's questionnaire. The third part is a retrospective non-interventional study where each doctor will collect retrospective data from selected subjects with COPD from the time of informed consent up to 12 months before. The retrospective data will be collected from subject files of approximately 250 subjects with COPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Doctor's questionnaire | The survey of physicians will be performed using doctor's questionnaire, which will be developed by lung specialists who are not participating in the survey. |
| OTHER | Subject file | All subject-based data will be obtained by retrospective evaluation of subject files available at the treating lung specialist. |
Timeline
- Start date
- 2018-04-19
- Primary completion
- 2018-08-30
- Completion
- 2018-08-30
- First posted
- 2018-03-14
- Last updated
- 2019-01-15
Locations
26 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT03465332. Inclusion in this directory is not an endorsement.